Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126968261 | 12696826 | 1 | I | 20160811 | 20160830 | 20160830 | PER | JP-LUPIN PHARMACEUTICALS INC.-2016-03853 | LUPIN | TAISUKE A, OSAMU H, YASUTAKA F, KEIJI S, RIE T, KENJI Y, NORIKO I, SATOSHI H, NOBUYA N. TWO CASES OF SEVERE LEGIONELLA INFECTION BECAUSE OF NOT TAKING ANTI-LEGIONELLA AT THE FIRST STAGE OF DISEASE OUTBREAK. THE 66TH KINKI REGIONAL MEETING OF JAPANESE SOCIETY OF INTENSIVE CARE MEDICINE (9/07/2016) / OSAKA CITY, OSAKA. 2016 JUL 09;43:. | 50.00 | YR | M | Y | 0.00000 | 20160830 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126968261 | 12696826 | 1 | PS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Unknown | UNKNOWN | 65398 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126968261 | 12696826 | 1 | Legionella infection |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126968261 | 12696826 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |